These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35771295)

  • 1. Huntington's disease and neurovascular structure of retina.
    Amini E; Moghaddasi M; Habibi SAH; Azad Z; Miri S; Nilforushan N; Mirshahi R; Cubo E; Mohammadzadeh N; Rohani M
    Neurol Sci; 2022 Oct; 43(10):5933-5941. PubMed ID: 35771295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is retina affected in Huntington's disease? Is optical coherence tomography a good biomarker?
    Dusek P; Kopal A; Brichova M; Roth J; Ulmanova O; Klempir J; Preiningerova JL
    PLoS One; 2023; 18(2):e0282175. PubMed ID: 36827300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington's disease.
    Murueta-Goyena A; Del Pino R; Acera M; Teijeira-Portas S; Romero D; Ayala U; Fernández-Valle T; Tijero B; Gabilondo I; Gómez Esteban JC
    J Neurol; 2023 Aug; 270(8):3821-3829. PubMed ID: 37079031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal single-layer analysis with optical coherence tomography shows inner retinal layer thinning in Huntington's disease as a potential biomarker.
    Gulmez Sevim D; Unlu M; Gultekin M; Karaca C
    Int Ophthalmol; 2019 Mar; 39(3):611-621. PubMed ID: 29435796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing differences in retinal and choroidal microvasculature and structure in individuals with Huntington's Disease compared to healthy controls: A cross-sectional prospective study.
    Joseph S; Robbins CB; Haystead A; Hemesath A; Allen A; Kundu A; Ma JP; Scott BL; Moore KPL; Agrawal R; Gunasan V; Stinnett SS; Grewal DS; Fekrat S
    PLoS One; 2024; 19(1):e0296742. PubMed ID: 38289919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset.
    Schmid RD; Remlinger J; Abegg M; Hoepner R; Hoffmann R; Lukas C; Saft C; Salmen A
    Brain Behav; 2022 Jun; 12(6):e2592. PubMed ID: 35511084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease.
    Andrade C; Beato J; Monteiro A; Costa A; Penas S; Guimarães J; Reis FF; Garrett C
    Mov Disord; 2016 Mar; 31(3):377-83. PubMed ID: 26853218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression.
    Kersten HM; Danesh-Meyer HV; Kilfoyle DH; Roxburgh RH
    J Neurol; 2015 Nov; 262(11):2457-65. PubMed ID: 26233693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography angiography findings in Huntington's disease.
    Di Maio LG; Montorio D; Peluso S; Dolce P; Salvatore E; De Michele G; Cennamo G
    Neurol Sci; 2021 Mar; 42(3):995-1001. PubMed ID: 32700226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography (OCT) study in Argentinean Huntington's disease patients.
    Gatto E; Parisi V; Persi G; Fernandez Rey E; Cesarini M; Luis Etcheverry J; Rivera P; Squitieri F
    Int J Neurosci; 2018 Dec; 128(12):1157-1162. PubMed ID: 29912591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography measurements in Huntington's disease: a systematic review and meta-analysis.
    Gouravani M; Fekrazad S; Mafhoumi A; Ashouri M; DeBuc DC
    J Neurol; 2024 Oct; 271(10):6471-6484. PubMed ID: 39187741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retina ganglion cell/inner plexiform layer and peripapillary nerve fiber layer thickness in patients with acromegaly.
    Şahin M; Şahin A; Kılınç F; Yüksel H; Özkurt ZG; Türkcü FM; Pekkolay Z; Soylu H; Çaça İ
    Int Ophthalmol; 2017 Jun; 37(3):591-598. PubMed ID: 27492731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced macular thickness and macular vessel density in early-treated adult patients with PKU.
    Serfozo C; Barta AG; Horvath E; Sumanszki C; Csakany B; Resch M; Nagy ZZ; Reismann P
    Mol Genet Metab Rep; 2021 Jun; 27():100767. PubMed ID: 34026550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeatability of peripapillary retinal nerve fiber layer and inner retinal thickness among two spectral domain optical coherence tomography devices.
    Matlach J; Wagner M; Malzahn U; Göbel W
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6536-46. PubMed ID: 25228545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OCT in Alzheimer's disease: thinning of the RNFL and superior hemiretina.
    Cunha JP; Proença R; Dias-Santos A; Almeida R; Águas H; Alves M; Papoila AL; Louro C; Castanheira-Dinis A
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1827-1835. PubMed ID: 28643042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of retinal nerve fiber layer and macular thickness for discriminating primary open-angle glaucoma and normal-tension glaucoma using optical coherence tomography.
    Khanal S; Davey PG; Racette L; Thapa M
    Clin Exp Optom; 2016 Jul; 99(4):373-81. PubMed ID: 26996257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Peripapillary Radial Capillary Plexus Alterations in Parkinson's Disease Using OCT Angiography.
    Robbins CB; Grewal DS; Thompson AC; Soundararajan S; Yoon SP; Polascik BW; Scott BL; Fekrat S
    Ophthalmol Retina; 2022 Jan; 6(1):29-36. PubMed ID: 33713852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography findings in chronic progressive external ophthalmoplegia.
    Wu Y; Kang L; Wu HL; Hou Y; Wang ZX
    Chin Med J (Engl); 2019 May; 132(10):1202-1207. PubMed ID: 31140991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegeneration with Brain Iron Accumulation Disorders and Retinal Neurovascular Structure.
    Amini E; Rohani M; Fasano A; Azad Z; Miri S; Habibi SAH; Emamikhah M; Mirshahi R; Joghataei MT; Gholibeigian Z; Ghasemi Falavarjani K
    Mov Disord; 2024 Feb; 39(2):411-423. PubMed ID: 37947042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal Vascular and Neural Remodeling Secondary to Optic Nerve Axonal Degeneration: A Study Using OCT Angiography.
    Parrozzani R; Leonardi F; Frizziero L; Trevisson E; Clementi M; Pilotto E; Fusetti S; Miglionico G; Midena E
    Ophthalmol Retina; 2018 Aug; 2(8):827-835. PubMed ID: 31047537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.